TPSF
ACOR

Texas Permanent School Fund’s Acorda Therapeutics ACOR Stock Holding History

Texas Permanent School Fund’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-340
Closed -$38K – 1526
2020
Q1 		$38K Buy
340
+66
+24% +$13K ﹤0.01% 1514
2019
Q4 		$67K Buy
274
+1
+0.4% +$252 ﹤0.01% 1517
2019
Q3 		$94K Buy
273
+47
+21% +$25.5K ﹤0.01% 1504
2019
Q2 		$208K Buy
226
+2
+0.9% +$2.46K ﹤0.01% 1470
2019
Q1 		$357K Buy
224
+9
+4% +$16.2K 0.01% 1396
2018
Q4 		$402K Buy
215
+8
+4% +$17.4K 0.01% 1338
2018
Q3 		$487K Sell
207
-46
-18% -$142K 0.01% 1344
2018
Q2 		$872K Sell
253
-6
-2% -$18.4K 0.01% 1168
2018
Q1 		$734K Sell
259
-4
-2% -$12K 0.01% 1200
2017
Q4 		$678K Sell
263
-21
-7% -$59.7K 0.01% 1243
2017
Q3 		$805K Hold
284
– – 0.01% 1209
2017
Q2 		$671K Buy
284
+4
+1% +$7.92K 0.01% 1256
2017
Q1 		$706K Hold
280
– – 0.01% 1219
2016
Q4 		$632K Sell
280
-13
-4% -$30.9K 0.01% 1269
2016
Q3 		$734K Sell
293
-1
-0.3% -$2.98K 0.01% 1194
2016
Q2 		$898K Sell
294
-7
-2% -$22.8K 0.01% 1114
2016
Q1 		$954K Buy
301
+3
+1% +$12.5K 0.01% 1106
2015
Q4 		$1.53M Buy
298
+3
+1% +$13.1K 0.02% 899
2015
Q3 		$939K Sell
295
-8
-3% -$31K 0.01% 1117
2015
Q2 		$1.21M Sell
303
-17
-5% -$65.7K 0.01% 1068
2015
Q1 		$1.28M Buy
320
+5
+2% +$22.9K 0.01% 1078
2014
Q4 		$1.54M Hold
315
– – 0.02% 990
2014
Q3 		$1.28M Sell
315
-36
-10% -$135K 0.01% 1041
2014
Q2 		$1.42M Buy
351
+4
+1% +$16.3K 0.01% 1073
2014
Q1 		$1.58M Sell
347
-15
-4% -$60.6K 0.02% 1017
2013
Q4 		$1.27M Buy
362
+3
+0.8% +$11.7K 0.01% 1124
2013
Q3 		$1.48M Sell
359
-20
-5% -$86.1K 0.02% 1030
2013
Q2 		$1.5M Buy
+379
New +$1.56M 0.02% 1013

Other funds holding ACOR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Texas Permanent School Fund's ACOR Position: Q2 2020 in Review

Texas Permanent School Fund sold out of Acorda Therapeutics (ACOR) in Q2 2020, closing a stake of 340 shares — an estimated $38K sold.

Texas Permanent School Fund first reported a position in ACOR in Q2 2013 and held it in 28 quarters. The position peaked at $1.58M in Q1 2014. 79 funds tracked by Wall St. Rank hold ACOR as of Q2 2020.

  • Texas Permanent School Fund reported no remaining Acorda Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Texas Permanent School Fund sold 340 Acorda Therapeutics shares in Q2 2020, an estimated $38K.
  • Texas Permanent School Fund first reported a position in Acorda Therapeutics in Q2 2013 and held it in 28 quarters.
  • Texas Permanent School Fund's Acorda Therapeutics position peaked at $1.58M in Q1 2014.
  • 79 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2020.

Based on Texas Permanent School Fund's 13F filing for Q2 2020, filed 4 Aug 2020.